Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vericel (VCEL) Research & Development (2016 - 2025)

Historic Research & Development for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $6.3 million.

  • Vericel's Research & Development rose 369.28% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 184.86%. This contributed to the annual value of $24.8 million for FY2024, which is 1784.53% up from last year.
  • Per Vericel's latest filing, its Research & Development stood at $6.3 million for Q3 2025, which was up 369.28% from $6.7 million recorded in Q2 2025.
  • Vericel's Research & Development's 5-year high stood at $7.4 million during Q2 2024, with a 5-year trough of $3.6 million in Q1 2021.
  • For the 5-year period, Vericel's Research & Development averaged around $5.4 million, with its median value being $5.2 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first surged by 4706.49% in 2021, then tumbled by 858.35% in 2025.
  • Over the past 5 years, Vericel's Research & Development (Quarter) stood at $3.9 million in 2021, then skyrocketed by 33.66% to $5.2 million in 2022, then dropped by 6.56% to $4.9 million in 2023, then increased by 0.45% to $4.9 million in 2024, then grew by 28.34% to $6.3 million in 2025.
  • Its Research & Development was $6.3 million in Q3 2025, compared to $6.7 million in Q2 2025 and $7.3 million in Q1 2025.